Menu Back to Medical-Affairs-and-Scientific-Communications-Forum

Overview

March 10-11: Primer
March 16: Short Course
March 17: Short Course
March 18: Short Course
March 21-23: Forum

DIA is offering both a live in-person and a live-stream virtual option for the Medical Affairs and Scientific Communications Forum. Upon registration, please indicate via the check box which avenue you are registering for: in-person or virtual.

DIA’s Medical Affairs and Scientific Communications Forum is designed for medical affairs professionals, by medical affairs professionals. This forum provides a comprehensive understanding of the regulatory and compliance environment directly affecting the daily activities of medical affairs and scientific communication professionals. Made up of multiple general and breakouts sessions within three tracks covering medical communications, medical writing, and medical science liaisons, you can pick and choose which sessions to attend and create your own unique forum.

Social distancing measures may be in place at the time of the event. Therefore, we encourage you to register and make your housing arrangements early due to potential limited capacity. If the capacity limit is reached, we will only be able to offer the virtual option. Don’t miss out on your chance to meet live again with your friends and colleagues!

We are thrilled to able to offer flexibility to our attendees to attend in-person or virtually. Please note, we are also offering that flexibility to our speakers so you will experience some speakers presenting remotely.



Who should attend?

Professionals involved in:

  • Medical Communications
  • Medical Writing
  • Medical Science Liaisons
  • Medical Information
  • Medical Call Center Environment
  • Regulatory Affairs
  • Clinical Research
  • Professional Education, Training, and Development
  • Document Management/eSubmissions

Program Committee

  • Dannis  Chang, PharmD
    Dannis Chang, PharmD Executive Director, Head of Medical Capabilities
    Mirati Therapeutics , United States
  • Amy  Van Sant, PharmD, MBA
    Amy Van Sant, PharmD, MBA President, Medical Affairs
    Ashfield Engage, United States
  • David  Meats
    David Meats Associate Director, Regulatory Services Management
    Certara Synchrogenix, United States
  • J. Lynn  Bass, PharmD, RPh
    J. Lynn Bass, PharmD, RPh Senior Director, Medical Sciences
    Medexus Pharma, United States
  • Ruggero  Galici, PhD
    Ruggero Galici, PhD Director, Nonclinical and Clinical Pharmacology Writing
    Alexion Pharmaceuticals, AstraZeneca Rare Disease, United States
  • Hanady  Elhadidy, PharmD
    Hanady Elhadidy, PharmD Director, US MI & Global Escalations
    Bristol Myers Squibb, United States
  • Michelle  Kissner, PharmD, RPh
    Michelle Kissner, PharmD, RPh Director, Publications Management
    Pfizer Inc, United States
  • Marie-Ange  Noue, PhD
    Marie-Ange Noue, PhD Senior Director, Head of Scientific Communications
    EMD Serono, Canada
  • Sonia  Sandhu, PharmD
    Sonia Sandhu, PharmD Director, Medical Information
    Gilead Sciences, Inc., United States
  • Robert  Tamburri, PharmD, MBA
    Robert Tamburri, PharmD, MBA Director, Medical Information Communication Channel
    Janssen Scientific Affairs, LLC, United States
  • Diane  Cleverley, PhD
    Diane Cleverley, PhD Senior Regulatory Writer
    Synchrogenix, a Certara Company, United States
  • Jennie  Jacobson, PhD
    Jennie Jacobson, PhD Associate Director, Publications and Scientific Communications
    Incyte, United States
  • Meera  Kodukulla, PhD
    Meera Kodukulla, PhD Senior Director, Scientific Publications
    AstraZeneca, United States
  • Andrea Tuttle Meyers
    Andrea Tuttle Meyers Senior Vice President, Medical Writing
    Syneos Health, United States
  • Donna  Booth, PharmD
    Donna Booth, PharmD Director, Field Medical HTA and Policy, US Medical Affairs
    GlaxoSmithKline, United States
  • Danielle  Day, PhD
    Danielle Day, PhD Senior Medical Director, Immunology, Rare Disease
    Sobi, United States
  • Sonja  Hokett, PharmD, MS
    Sonja Hokett, PharmD, MS Executive Director/Head of Medical Managed Care
    BioXcel Therapeutics, United States
  • Paul  Minne, PharmD, RPh
    Paul Minne, PharmD, RPh Director, MSL Team
    Neurocrine Biosciences, United States
  • Kay  Uttech, PharmD, MA, RPh
    Kay Uttech, PharmD, MA, RPh VP, Strategic Initiatives
    Indegene, United States
Load More